These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2654132)

  • 1. Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene.
    Brunner G; Pohl J; Erkell LJ; Radler-Pohl A; Schirrmacher V
    J Cancer Res Clin Oncol; 1989; 115(2):139-44. PubMed ID: 2654132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator biosynthesis is induced by the EJ-Ha-ras oncogene in CL26 mouse colon carcinoma cells.
    Testa JE; Medcalf RL; Cajot JF; Schleuning WD; Sordat B
    Int J Cancer; 1989 May; 43(5):816-22. PubMed ID: 2497073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynolds LM
    J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the malignant phenotype with the urokinase-type plasminogen activator and the type I plasminogen activator inhibitor.
    Sordat B; Reiter L; Cajot JF
    Cell Differ Dev; 1990 Dec; 32(3):277-85. PubMed ID: 2129155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of metastasis by inhibition of the urokinase receptor.
    Crowley CW; Cohen RL; Lucas BK; Liu G; Shuman MA; Levinson AD
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5021-5. PubMed ID: 8389464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
    Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
    Pakneshan P; Szyf M; Rabbani SA
    Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenic behaviour of c-Ha-ras oncogene transfected CaCo 2 cells is associated with increased proteolytic potency.
    de Vries JE; van Driel M; Marx P; van der Linden EP; de Bruin L; Moerkerk P; Verspaget HW; Bosman FT; Ten Kate J
    Anticancer Res; 1996; 16(1):321-6. PubMed ID: 8615629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
    Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased invasion of neuroglioma cells transfected with urokinase plasminogen activator receptor cDNA.
    Mohanam S; Chintala SK; Mohan PM; Sawaya R; Lagos GK; Gokaslan ZL; Kouraklis GP; Rao JS
    Int J Oncol; 1998 Dec; 13(6):1285-90. PubMed ID: 9824646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells.
    Tavian D; Salvi A; De Petro G; Barlati S
    Cancer Gene Ther; 2003 Feb; 10(2):112-20. PubMed ID: 12536199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
    Yu HR; Schultz RM
    Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of urokinase-related genes in superficial and invasive transitional cell carcinoma.
    McGarvey TW; Kariko K; Barnathan ES; Thomas J; Malkowicz SB
    Int J Oncol; 1998 Jan; 12(1):175-80. PubMed ID: 9454902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
    Albo D; Rothman VL; Roberts DD; Tuszynski GP
    Br J Cancer; 2000 Aug; 83(3):298-306. PubMed ID: 10917542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras.
    Price JE; Aukerman SL; Ananthaswamy HN; McIntyre BW; Schackert G; Schackert HK; Fidler IJ
    Cancer Res; 1989 Aug; 49(15):4274-81. PubMed ID: 2663141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.
    Lyu MA; Choi YK; Park BN; Kim BJ; Park IK; Hyun BH; Kook YH
    Int J Cancer; 1998 Jul; 77(2):257-63. PubMed ID: 9650562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.
    Cajot JF; Schleuning WD; Medcalf RL; Bamat J; Testuz J; Liebermann L; Sordat B
    J Cell Biol; 1989 Aug; 109(2):915-25. PubMed ID: 2503527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H; Sheng S
    Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator and its receptor in bladder cancer.
    Hasui Y; Osada Y
    J Natl Cancer Inst; 1997 May; 89(10):678-9. PubMed ID: 9168177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.